Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tristan J Barber

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Sexually Transmitted Infections|December 24, 2017
BASHH HIV and Blood Borne Virus Specialist Interest GroupTristan J Barber
The Lancet. HIV|May 10, 2019
Bictegravir and dolutegravir: head to head at 96 weeksTristan J Barber
AIDS (London, England)|July 19, 2006
Response to Waters et al. 'Successful use of genotypic resistance testing in HIV-1-infected individuals with detectable viraemia between 50 and 1000 copies/ml'Tristan J Barber
Medicine (Abingdon, England : UK Ed.)|April 4, 2022
Non-infective complications for people living with HIVLouisa Chenciner, Tristan J Barber
The Journal of Family Planning and Reproductive Health Care|January 19, 2008
Implanon failure and antiretroviral therapyTristan J Barber, Laura Waters
Current Problems in Cardiology|March 2, 2024
Letter to the editor of current problems in cardiologyVladislav Zlatkin, Tristan J Barber
The Lancet. HIV|October 2, 2015
FLAMINGO: still in the pink?Tristan J Barber, Anton Pozniak
Current Opinion in HIV and AIDS|June 15, 2010
Postexposure prophylaxis for HIV following sexual exposureTristan J Barber, Paul D Benn
Journal of Virus Eradication|March 4, 2021
Glasgow HIV conference on HIV Drug Therapy 2020Tristan J Barber, Laura J Waters
Lancet (London, England)|January 12, 2013
Dolutegravir for treatment of HIV: SPRING forwards?Laura J Waters, Tristan J Barber
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Sexually Transmitted Infections|December 24, 2017
BASHH HIV and Blood Borne Virus Specialist Interest GroupTristan J Barber
The Lancet. HIV|May 10, 2019
Bictegravir and dolutegravir: head to head at 96 weeksTristan J Barber
AIDS (London, England)|July 19, 2006
Response to Waters et al. 'Successful use of genotypic resistance testing in HIV-1-infected individuals with detectable viraemia between 50 and 1000 copies/ml'Tristan J Barber
Medicine (Abingdon, England : UK Ed.)|April 4, 2022
Non-infective complications for people living with HIVLouisa Chenciner, Tristan J Barber
The Journal of Family Planning and Reproductive Health Care|January 19, 2008
Implanon failure and antiretroviral therapyTristan J Barber, Laura Waters
Current Problems in Cardiology|March 2, 2024
Letter to the editor of current problems in cardiologyVladislav Zlatkin, Tristan J Barber
The Lancet. HIV|October 2, 2015
FLAMINGO: still in the pink?Tristan J Barber, Anton Pozniak
Current Opinion in HIV and AIDS|June 15, 2010
Postexposure prophylaxis for HIV following sexual exposureTristan J Barber, Paul D Benn
Journal of Virus Eradication|March 4, 2021
Glasgow HIV conference on HIV Drug Therapy 2020Tristan J Barber, Laura J Waters
Lancet (London, England)|January 12, 2013
Dolutegravir for treatment of HIV: SPRING forwards?Laura J Waters, Tristan J Barber
Pageof 6